Epidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib
Roseann Mulloy(Harvard University), Jeffrey Settleman(Harvard University)
Cited by 191
Related Papers
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
|Genes & Development|2007|445